380 filings
Page 2 of 19
8-K
r418m4tlw9dtjl
21 Jul 23
ARCA biopharma Announces Second Quarter 2023 Financial Results
4:35pm
8-K
htvn7nur3qjmfsg7s4
24 Apr 23
ARCA biopharma Announces First Quarter 2023 Financial Results
4:35pm
8-K
08et4fnjdywqqv
24 Feb 23
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
4:31pm
8-K
533qxe79
13 Feb 23
Departure of Directors or Certain Officers
4:30pm
8-K
t67hn mijhn2
19 Dec 22
JaMES FLYNN joins arca biopharma board of directors
4:16pm
8-K
lzn9bde 8zgduc
9 Dec 22
Departure of Directors or Certain Officers
4:15pm
8-K
svwn0 mj5
28 Oct 22
ARCA biopharma Announces Third Quarter 2022 Financial Results
4:25pm
8-K
je9nmp rkj9
20 Oct 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:15pm
8-K
ebb 6nj2cdeb77h0k6qx
2 Aug 22
ARCA biopharma Announces Second Quarter 2022 Financial Results
4:31pm
8-K
ggbrw02 ex6oiu2h0z5
21 Jun 22
Jacob ma-weaver joins arca biopharma board of DIRECTORS
2:30pm
8-K
0jikaqc7j7o
5 May 22
ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review
12:00am
8-K
m6vejc3c
2 May 22
ARCA biopharma Announces First Quarter 2022 Financial Results
4:23pm
8-K
ojwaaf mpnir2pfc8ie8
18 Apr 22
ARCA biopharma Establishes Special Committee of the Board of Directors
4:46pm
8-K
3m0pdox4 x0hprk8us
31 Mar 22
ARCA biopharma Reports Topline Results for ASPEN-COVID-19
4:34pm
8-K
ymnhng9b 53
14 Mar 22
ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update
4:26pm
8-K
7fhnb978 6x
16 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
gkbemlt7axhj2jd81pe
2 Dec 21
Topline readout of clinical trial results anticipated in first quarter of 2022
4:16pm
8-K
w4vx0s92xos8i3ke
2 Nov 21
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update
4:31pm
8-K
ze5fp4 vonatw136us
28 Oct 21
ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clinical Trial to Completion Based on Interim Analysis of Efficacy
4:38pm
8-K
zs5eg1
16 Sep 21
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
4:15pm